We are live on ! Find out more
NDRM

NeuroDerm Ltd. Ordinary Shares
NDRM

Delisted

NDRM was delisted on the 17th of October, 2017.

Back to rankings

15 hedge funds and large institutions have $21.2M invested in NeuroDerm Ltd. Ordinary Shares in 2015 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

2% more capital invested

Capital invested by funds: $20.7M → $21.2M (+$515K)

0% more funds holding

Funds holding: 15 → 15 (0)

0% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 4

0% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 3

Holders
15
Holders Change
–
Holders Change %
0%
% of All Funds
0.4%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
3
Reduced
3
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
ACP
Acuta Capital Partners
California
+$1.27M
2
EEG
E.E. Geduld
+$431K
3
OC
Oppenheimer & Co
New York
+$47.4K
4
Alyeska Investment Group
Alyeska Investment Group
Illinois
+$47.1K
5
TI
Turner Investments
Pennsylvania
+$24.6K

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$190K
2
VKH
Virtu KCG Holdings
New York
-$150K
3
Deutsche Bank
Deutsche Bank
Germany
-$125K
4
Morgan Stanley
Morgan Stanley
New York
-$74.7K
5
Goldman Sachs
Goldman Sachs
New York
-$22.7K

NDRM Hedge Fund Activity: Q1 2015 in Review

15 of the 3,770 institutional investors tracked by Wall St. Rank reported a position in NeuroDerm Ltd. Ordinary Shares (NDRM) for Q1 2015, worth a combined $21.2M — up 2.5% from $20.7M a quarter earlier.

Fund positioning in NDRM was balanced in Q1 2015: 4 funds opened new positions, 4 closed out, 3 added to existing stakes and 3 trimmed.

The largest buyer was Acuta Capital Partners, opening a new position worth an estimated $1.27M. The largest seller was Citadel Advisors, exiting entirely with an estimated $190K sold.

  • 15 institutional investors held NeuroDerm Ltd. Ordinary Shares (NDRM) as of Q1 2015, unchanged from Q4 2014.
  • Funds reported $21.2M of NeuroDerm Ltd. Ordinary Shares stock for Q1 2015, up 2.5% quarter-over-quarter.
  • 4 funds opened new NeuroDerm Ltd. Ordinary Shares positions in Q1 2015 and 4 closed out, a net change of 0 holders.
  • The largest NeuroDerm Ltd. Ordinary Shares buyer in Q1 2015 was Acuta Capital Partners, an estimated $1.27M added.
  • The largest NeuroDerm Ltd. Ordinary Shares seller in Q1 2015 was Citadel Advisors, an estimated $190K sold.

Based on aggregated 13F filings for Q1 2015.